首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current treatment options in neurology

缩写:CURR TREAT OPTION NE

ISSN:1092-8480

e-ISSN:1534-3138

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引142条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Angelo Schenone,Lucilla Nobbio,Margherita Monti Bragadin et al. Angelo Schenone et al.
Inherited peripheral neuropathies are among the most common hereditary diseases of the nervous system. Charcot-Marie-Tooth (CMT) disease, also known from previous classifications as hereditary motor and sensory neuropathy (HMSN), is certain...
Lindsay Zilliox,James W Russell Lindsay Zilliox
No current disease-modifying treatments have been shown definitively in randomized clinical trials to reduce or reverse diabetic sensory polyneuropathy (DSP). It is increasingly recognized that individuals with "prediabetes" or impaired glu...
Navaz Karanjia,Romergryko G Geocadin Navaz Karanjia
Treatment of cardiac arrest should focus on maximizing neurologic recovery as well as systemic recovery to ensure the best possible functional outcome. This article focuses on the neurologic care of patients after they have been resuscitate...
Glenn Lopate,Alan Pestronk Glenn Lopate
The primary goal of therapy in patients with the Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is improved strength and functional ability. Improvement in pain, sensory loss, gait disord...
Joshua N Goldstein,Aaron J Gilson Joshua N Goldstein
Intracerebral hemorrhage is a medical emergency. It is the most deadly and disabling form of stroke, and no individual therapy has been demonstrated to improve outcome. However, it appears that aggressive medical care in general, and manage...
B Jane Distad,Anthony A Amato,Michael D Weiss B Jane Distad
The mainstay of treatment for the idiopathic inflammatory myopathies currently and traditionally has been therapeutics aimed at suppressing or modifying the immune system. Most therapies being used are directed towards polymyositis (PM) and...
Guido Cavaletti,Paola Alberti,Barbara Frigeni et al. Guido Cavaletti et al.
Chemotherapy-induced peripheral neurotoxicity (CIPN) is one of the most severe and unpredictable side effects of modern anticancer treatment. In recent years, a clear understanding of the importance of an integrated approach to CIPN has bec...
J Marc Simard,Juan Sahuquillo,Kevin N Sheth et al. J Marc Simard et al.
Managing patients with malignant cerebral infarction remains one of the foremost challenges in medicine. These patients are at high risk for progressive neurologic deterioration and death due to malignant cerebral edema, and they are best c...
Frederick R Taylor,Robert G Kaniecki Frederick R Taylor
Migraine is a biologic disorder of the brain characterized by a heterogeneous array of symptoms and episodes of disabling headache. By definition, such attacks last between 4 and 72 h without treatment, with the disability arising from a va...
Teshamae S Monteith,Peter J Goadsby Teshamae S Monteith
The conceptual shift of our understanding of migraine from a vascular disorder to a brain disorder has dramatically altered the approach to the development of new medicines in the field. Current pharmacologic treatments of acute migraine co...